Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.52 |
| ▸ | CA1 | P00915 | 5/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 2/20 | 0.32 |
| ▸ | MMP2 | P08253 | 2/20 | 0.32 |
| ▸ | MMP9 | P14780 | 2/20 | 0.32 |
| ▸ | MMP8 | P22894 | 2/20 | 0.32 |
| ▸ | MMP13 | P45452 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL278189 | 0.97 | CA2 (0.55) | CA2CA1CA7CA13MAPK1 | |
| SCHEMBL2230683 | 0.94 | CA2 (0.52) | CA2CA1CA7CA13MAPK1 | |
| Ammonia Solution, Strong SCHEMBL17435849 | 0.94 | CA2 (0.52) | CA2CA1CA7CA13MAPK1 | |
| SCHEMBL2230987 | 0.94 | CA2 (0.52) | CA2CA1CA7CA13MAPK1 | |
| SCHEMBL17435914 | 0.94 | CA2 (0.52) | CA2CA1CA7CA13MAPK1 | |
| Lithium SCHEMBL30614030 | 0.94 | CA2 (0.52) | CA2CA1CA7CA13MAPK1 | |
| Cesium SCHEMBL30614080 | 0.94 | CA2 (0.52) | CA2CA1CA7CA13MAPK1 | |
| Dimethylamine SCHEMBL17435944 | 0.89 | CA1 (0.48) | CA2CA1CA7CA13MAPK1 | |
| Tetramethylammonium Ion SCHEMBL17435895 | 0.87 | CA1 (0.46) | CA2CA1MAPK1SMN1; SMN2EPHX1 | |
| Trimethylammonium SCHEMBL17435850 | 0.87 | CA1 (0.46) | CA2CA1MAPK1SMN1; SMN2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11345657-B2 | Sulfamic acid derivatives and processes for their preparation | HYDRO-QUEBEC (CA) | 2022-05-31 | — | — | US | disclosed |
| US-20200181071-A1 | SULFAMIC ACID DERIVATIVES AND PROCESSES FOR THEIR PREPARATION | HYDRO-QUéBEC (CA) | 2020-06-11 | — | — | US | disclosed |
| US-9950929-B2 | Method for producing disulfonylamine alkali metal salt | NIPPON SODA CO., LTD. (JP) | 2018-04-24 | — | — | US | disclosed |
| EP-2977349-A1 | METHOD FOR PRODUCING DISULFONYLAMINE ALKALI METAL SALT | Nippon Soda Co., Ltd. (JP) | 2016-01-27 | — | — | EP | disclosed |
| US-20160016797-A1 | METHOD FOR PRODUCING DISULFONYLAMINE ALKALI METAL SALT | NIPPON SODA CO., LTD. (JP) | 2016-01-21 | — | — | US | disclosed |
| US-8936674-B2 | Conductive silica sol composition, and molded article produced using the same | MITSUBISHI MATERIALS CORPORATION (JP) | 2015-01-20 | — | — | US | disclosed |
| US-20110210295-A1 | Conductive silica sol composition, and molded article produced using the same | MITSUBISHI MATERIALS CORPORATION (JP) | 2011-09-01 | — | — | US | disclosed |
| EP-2354206-A1 | ELECTRICALLY CONDUCTIVE SILICA SOL COMPOSITION AND MOLDED ARTICLE PRODUCED BY USING SAME | Mitsubishi Materials Corporation (JP) | 2011-08-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11345657-B2 | Sulfamic acid derivatives and processes for their preparation | STS, SCLY, MPST | CA2 155/4885CA1 16/4885CA7 76/4885 |
| US-20200181071-A1 | SULFAMIC ACID DERIVATIVES AND PROCESSES FOR THEIR PREPARATION | STS, SCLY, MPST | CA2 155/4885CA1 16/4885CA7 76/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.